(continued)
- Tecentriq Hybreza (atezolizumab/hyaluronidase-tqjs)
- Revuforj (Revumenib)
- Kisunla (donanemab-azbt)
- Ojemda (tovorafenib)
- Myhibbin (mycophenolate mofetil)
- Augtyro (repotrectinib)
- Lyfgenia (lovotibeglogene autotemcel)
- Casgevy (exagamglogene autotemcel)
- Akeega (niraparib/abiraterone)
- Columvi (glofitamab-gxbm)
- Vanflyta (quizartinib)
- Jaypirca (pirtobrutinib)
- Daybue (Trofinetide)
- Tecvayli (teclistamab-cqyv)
- Elahere (mirvetuximab soravtansine-gynx)
- Zynteglo (betibeglogene autotemcel)
- Vonjo (pacritinib)
- Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
- Scemblix (asciminib)
- Besremi (Ropeginterferon Alfa-2b)
- Zynlonta (loncastuximab tesirine-lpyl)
- Jemperli (dostarlimab-gxly)
- Tepmetko (tepotinib)
- Breyanzi (lisocabtagene maraleucel)
- Onureg (azacitidine)
- Gavreto (pralsetinib)
- Orgovyx (relugolix)
- Phesgo (pertuzumab/trastuzumab/hyaluronidase-zzxf)
- Inqovi (decitabine/cedazuridine)
- Tabrecta (capmatinib)
- How Does Enhertu Work for Breast Cancer?
- How Pluvicto Fights Prostate Cancer and What to Expect